Clinical Trial Detail

NCT ID NCT02308761
Title A Dose Escalation and Cohort Expansion Study of TEN-010 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tensha Therapeutics
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

TEN-010

Age Groups: adult

No variant requirements are available.